CyberHeart’s cardiac arrhythmia ablation treatment: Patients with Refractory Ventricular Tachycardia / Fibrillation
Study Type/Phase: Pilot
Status: Not Recruiting
Ventricular Tachycardia (VT) is a pathological cardiac rhythm originating independently within the ventricles (primary pumping chambers) of the heart. VT can cause significant mortality and morbidity (side effects) by directly causing death or inducing syncope (lightheadedness), pulmonary edema (fluid in lungs), palpitations (rapid irregular heartbeats), and significant distress via recurrent discharges in those with implantable cardioverter defibrillators(ICDs).
Currently, there are several options for preventing and terminating VT. The options include pharmacological (prescription drug) therapy, electrical cardioversion (ICD), and catheter ablation (CA), all of which have side effects. CyberHeart, Inc. has developed a noninvasive (staying outside the body) software technology, called CardioPlan™, to utilize a radiosurgery platform to minimally ablate (scar, destroy) cardiac tissue that is causing a very fast heart beat (VT).
The objective of this clinical investigation is to evaluate the safety and efficacy of the CyberHeart System utilizing the already approved CyberKnife® machine, in patients with refractory (therapy resistant) ventricular tachycardia who have no viable options left.
The CyberKnife is a frameless robotic system that is used for delivering external x-ray beams in a process called stereotactic radiotherapy. This type of procedure uses precisely focused radiation beams to treat tumors and other problems in various parts of the body. In this study, radiotherapy will be delivered to the abnormal pathways in the heart using the CyberKnife system. We will investigate whether this approach is a viable alternative for abnormal heart rhythms.
Up to 5 patients will be enrolled at El Camino Hospital Mountain View location.
Speak with your doctor to determine whether you meet the following criteria for participation in this study.
|Inclusion Criteria||Exclusion Criteria|